In the first episode of the Imagion Biosystems podcast series, Board member Dr John Hazle speaks on his background, the imaging sector and how he came to join Imagion.
Dr. Hazle is a medical physicist with over 25 years of experience. He is board-certified and licensed in Texas for both therapeutic and diagnostic medical physics. His research interests include image-guided therapy, pre-clinical imaging, and novel early detection technologies.
Imagion Biosystems HER2 Breast Cancer Program Update
October 7, 2025
Key Highlights: Manufacturing of the MagSense® HER2 Breast Cancer Imaging Agent for the Phase 2 clinical trial has been completed – major milestone achieved IBX,